DJIA 17,745.98 -5.41 -0.03%
NASDAQ 5,128.79 17.05 0.33%
S&P 500 2,108.63 0.06 0.00%
market minute promo

Gilead Sciences (NASDAQ: GILD)



company name or ticker
Company Photos
(Click to zoom)

Is Gilead A Buy Pre Earnings?

Stock Market News for July 27, 2015 - Market News

A Big Day For Biotech And It's Not Going So Well

The Importance Of Newly-Released Data For Gilead's HIV Drug Patent Cliff

Short Sellers Back Off Major Biotechs

BioPharma Earnings Bracing for Merck, Pfizer, Amgen, Gilead

1 ETF That’s Crushing Even Warren Buffett

Warren Buffett's Berkshire Hathaway has rarely been beaten by any fund for lengthy periods of time. But this ETF is doing it in spades. Here's how.

Gilead (GILD) to Report Q2 Earnings: Surprise in the Cards? - Analyst Blog

Why Dividend Growth Investing Is Not Always Best

Cramer -- Biogen's Brutal Selloff Is Warranted; Look to Other Biotech Winners

See More Articles...